Drug Therapy
FDA/CDC
FDA opens the door to biosimilar insulin
The agency published a final rule that transitions insulin and other products from regulation as a drug to a biologic.
FDA/CDC
New lipid-lowering drug earns FDA approval
News
As costs for neurologic drugs rise, adherence to therapy drops
In patients with Parkinson’s disease, dementia, and neuropathy, higher out-of-pocket drug prices were associated with lower adherence for common...
Latest News
Doctors look to existing drugs in coronavirus fight
News
Zilucoplan improved efficacy outcomes in myasthenia gravis
The complement C5 inhibitor had a similar magnitude of clinical effect as that seen in eculizumab studies.
Article
Lorcaserin withdrawn from U.S. market due to cancer risk
The Food and Drug Administration advised health care professionals to stop prescribing and dispensing lorcaserin and to contact patients who are...
News
Pathways to new therapeutic agents for human coronaviruses
News
Pharmacologic prophylaxis fails in pediatric migraine
A network meta-analysis of pharmacologic prophylaxis shows little evidence for efficacy in children.
Conference Coverage
Shift in approach is encouraged in assessing chronic pain
SAN DIEGO – “The time has come to move past using a one-size-fits-all approach to assess the fifth vital sign,” Dr. Bonakdar said.
FDA/CDC
FDA not recommending recalls of diabetes drug metformin
The FDA began testing samples of metformin for the carcinogen NDMA at the end of last year.